Vernon Yuen/Getty Images In response to the tremendous clinical progress of Elon Musk’s Neuralink, investors are pouring ...

Researchers at UC San Francisco have achieved a remarkable breakthrough in brain-computer interface (BCI) technology, enabling individuals with paralysis to control robotic devices through thought ...

Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product. Tech companies are always trying out new ways for people to interact with computers—consider ...

MintNeuro, a pioneer of scalable, low-power semiconductor technology for neural implant applications, and Motif Neurotech, a therapeutic brain-computer interface (BCI) company developing miniature ...

For individuals living with paralysis, the loss of physical abilities often leads to a stifling of creative expression. However, the advent of brain interface technology has created new opportunities ...

Explore how brain computer interface technology and advanced brain-computer interfaces are transforming digital interaction, potentially replacing traditional keyboards and screens with thought-driven ...

What are brain-computer interfaces? Brain-computer interfaces (BCIs) are devices that allow for the action or control of an external device from brain signals. These technologies have a broad range of ...

Apple is getting into the brain-computer interface (BCI) business, reveals a press release from New York-based startup Synchron. The idea is to enable people with limited mobility to use iPhones, ...

Recently, a neurotech company called Paradromics made headlines by successfully implanting its brain-computer interface (BCI) in a human for the first time. The procedure happened at the University of ...

Brain-computer interface technology has long belonged to the realm of science fiction, but it’s quickly emerging as a real-world innovation with the potential to transform how we live, work and ...

Earlier this week, the United States Food and Drug Administration (FDA) approved a human trial for a blueberry-sized brain ...